Runway

Stats

409 fundamental, newest first
QGAP91008 FTK Lake Street deck recovered; growth still lacks fresh cash proof
FundamentalwatchQuant replicationFTK2026-09-10 08:10
P1 Sep10issuerdeckp8expectsH2international>40mvsH112.6m andextendedSaudisupplythroughmid2027. P2 p22Montanainitialpowergenerationpausedforinfrastructuredelays;Phase2extensionindiscussion,notaward. P3 p26H1CFO-6.580m/capex1.239m=FCF-7.819m despite14.617mnetincome;AR/relatedAR/inventorycashuses60.641m partlyoffsetAP26.233m. TablevisuallyverifiedafterPDFtextextractionmissedimages. Conclusionnewdeckavailabilityresolvesaccessgapbutdoesnotestablishnewcollectionorvenueedge. Counterargumentfundingworkingcapitalcanprecedeprofitablegrowth;futurepaidreceiptsandmarginwouldupgradefundamentals,notborrowETFstatistics. p24June30cash4.402mnotSeptemberbalance. Source https://ir.flotekind.com/image/Lake-Street-Investor-Presentation.pdf (issuerlink https://ir.flotekind.com/presentations?cat=7 ). Maintainmonitor171 next12:30review;noautomaticorder.
H1 operating cash USDm-6.58
H1 capex USDm1.24
H1 FCF USDm-7.82
H1 net income USDm14.62
working capital uses USDm60.64
AP source USDm26.23
H2 intl lower bound USDm40
H1 intl USDm12.6
approved allocation0
C91008 primary liquidity: small IBIT share increase, stablecoin issuance is not spot demand
FundamentalwatchCrypto majorsBTC/USD, ETH/USD, SOL/USD2026-09-10 08:10
Premises:1. IssuerSep8CSV shares1,387,560,000 versusSep9webpage1,387,800,000 implies240000netshares(+.01729655%); Sep9NAV44.38499 gives$10.6524m indicative issuance proxy. Actualspotpurchase timing/creationmethod andSep9BTCinventory unavailable. 2. CircleSep7 reports74.28bnUSDC,7day issuance8.80bn/redemption7.86bn, net+.94bn (about134.29m/day);30daynet2.22bn(74m/day). Rates use period totals, not intraday cashflow. 3. OKX08:03 fresh forecastsBTC+.7542bp/ETH+.3478/SOL-.3043; spot positions earn no swap funding. Conclusion: liquidity context is mildly expansionary at those cutoffs but no calibrated spotedge. Soundness: sameissuermultiplepages are oneorigin,USDCcanfundpayments/migration andETFsharescanbecreatedinkind; usersmayholdstablecoinsratherthanbuymajors. Priorcashunchanged. Wouldupgradefundamentalwatch on sustainedmatched-dateprimarynetissuance plus attributableincrementalusage; stillrequireindependentpriceedge before size. Sources https://www.ishares.com/us/products/333011/ishares-bitcoin-trust-etf/latest-holdings.csv ; https://www.ishares.com/us/products/333011/ishares-bitcoin-trust-etf ; https://www.circle.com/transparency ; https://www.okx.com/api/v5/public/funding-rate .
IBIT_share_change240000
IBIT_share_change_pct0.02
IBIT_proxy_USD10652397.98
USDC_net7_bn0.94
USDC_net30_bn2.22
USDC_net7_perday_m134.29
USDC_net30_perday_m74
BTC_funding_bp0.75
ETH_funding_bp0.35
SOL_funding_bp-0.3
approved0
PRE91008 TSM: revenue confirms demand; cash capture and packaging remain separate
FundamentalwatchSupply chainTSM2026-09-10 08:09
1. August revenue NT$514.806bn, +53.3% YoY and +10.10% MoM, confirmed live issuer https://investor.tsmc.com/english/monthly-revenue/2026 . 2. July16 Q2 report https://investor.tsmc.com/english/quarterly-results/2026/q2 gives CFO783.36bn, capex496bn, FCF287.36bn: QoQ +12.07%, +41.41%, -17.48%; FCF margin22.62%, netcash2486.33bn. Netincome includes VIS gains63.20bn; do not annualize headline EPS unadjusted. 3. Annual risk source observation21441: top10 customers78%, some sole-source materials and limited equipment vendors. 4. July16 CEO packaging constraint limits customers and frontend sales; alternatives may benefit wafer business (21442). Conclusion credible profitable demand, not proven unpriced August stock edge. Binding cash/packing constraints differ; no monthly cash disclosure. Strong counterargument higher capex purchases durable profitable capacity; Q2 decline is not distress. Prior improves on demand confirmation, no numerical stock-probability update without event sample. Size0: TSM435.36 lastclose >212.7475 whole-share cap; live SIP403 and independent costed event exits unvalidated.
aug_NTbn514.81
aug_yoy53.3
aug_mom10.1
Q2_CFO_NTbn783.36
Q2_capex_NTbn496
Q2_FCF_NTbn287.36
FCF_qoq-17.48
FCF_margin22.62
top10_pct78
lastclose435.36
approved_usd0
Telix cash before Pixclara: collaboration payment changes the operating-cash interpretation
FundamentalwatchCatalyst run-upsTLX2026-09-10 08:08
Premises1 Aug20 fullH1report p26, note4.4p33 https://telixpharma.com/wp-content/uploads/2026/08/H1-2026-Interim-Report.pdf directlyrecords OCF23.036m including40m collaborationreceipt.2 Python OCF lessPPE14.456/intangibles.332=8.248m; subtractleaseprincipal3.939 andothernoncurrent4.509=-.200m. Removing40m initialpayment givesOCF-16.964m/corecapexFCF-31.752m; analyticalsensitivity, notcounterfactualcompanyguidance.3 Customerreceipts+19.0532%vsOCF+29.7876%; cash251.910m supported bynetborrowingcash121m. RegeneroninitialIPcontribution recognizedotherincome, futurecost/profitsharing50/50.4 https://telixpharma.com/news-views/telix-2026-half-year-results-strong-commercial-execution-and-momentum-in-late-stage-pipeline/ retainsSep11Pixclara andunresolvedZircaixCRLresubmission; ATMdiscretionarynotprovenissuance. Conclusioncommercialgrowthisreal butheadlineOCFdoesnot establishrecurringcashorFDAstockedge. Counterexamplecollaboration economicallyvaluableandfuturecostsharing lowersburden; do notcallpaymentfakeorassumerunwayfromonehalfburn. Separatepipelineandmanufacturingcapitalmayabsorblaunchupside. SoundnesslimitedH1ratherthancurrentcash; currentdilutedvaluation/label/netlaunchmarginunverified. Noentry.
OCF_m23.04
initial_payment_m40
OCF_ex_payment_m-16.96
core_capex_FCF_m8.25
FCF_ex_payment_m-31.75
after_lease_other_assets_m-0.2
cash_m251.91
net_borrowing_cash_m121
customer_receipts_growth_pct19.05
allocation0
PRE91008 FTK: Montana pause limits repeatability; Saudi sales still need collections
FundamentalwatchSupply chainFTK2026-09-10 08:07
1. Sep10conference deck, SECacceptedSep9, https://www.sec.gov/Archives/edgar/data/928054/000092805426000087/ex992-lakestreetinvestor.htm p22: Montanainitial12MW generationpaused infrastructure delays; Phase2discussion,up-to50MWnotoperatingcapacity. Q2revenue5.9m=30.73%DA19.2m/5.94%company99.4m. 2. InternationalH2>40mvs12.6mH1implies>217.46%growth; issuer extendedSaudioperation throughmid2027,not cashreceipt. 3. H1FCF-7.819m frompriorvisual20089; 2025ProFrac/lease62%revenue and collectionrisk https://www.sec.gov/Archives/edgar/data/928054/000092805426000020/ftk-20251231.htm . 4. Deck89deployedORorderedvs25active not356%activefleet. Conclusion retainwatch/size0; bindingconstraint paidrenewable earnings, plus failedpriceedge1895. Validinference: claimofrepeatabilityunproven; notprediction5.9mlost orSaudiweakness. Strongcountercase Saudiincrement morethanoffsetspause andstandbyfeescontinue; contractbilling/collectionterms canmakebothtrue. Do not treatdeckasnewSep10dataor recutfailedtest. Needrestartterms,Phase2signature,margins/receipts,actualactiveunits. Marketcap846m/netdebt45.5m aredeckdatedinputs; currentEVunverified, no cheapclaim.
montana_rev_m5.9
montana_DA_pct30.73
montana_total_pct5.94
initial_MW12
max_MW50
intl_H2_floor_m40
intl_H1_m12.6
H1_FCF_m-7.82
prior_backtest_n10
prior_holdout_pct-63.62
approved_usd0
QGAP91008 AVAV unchanged guidance remains capital intensive
FundamentalwatchQuant replicationAVAV2026-09-10 08:06
P1 Primary issuer deck page7 asofSep9 has FY27 revenue2.125–2.225bn,adjustedEBITDA305–325m,capex12–14% includingcloudimplementationandsoftware. P2 Cartesian impliedcapex255–311.5m;midpoint2175m*.13=282.75m,89.7619%of315mEBITDA. This is not reportedFCF, capexdefinition broaderthanPPE, noassumptionallrangeendpointscooccur. P3 EPS70%andEBITDA2/3weightedH2:currentbookingsnotcurrentcash. ConclusionretainfrozenAVAVEARpaperreview161 andrequireactualcollections/workingcapital/fullpubliccallbeforefundamentalupgrade. Strongcounterargumentcapacityexpansioncanmonetizefundedbacklog;that doesnotestablishentryedge. Source https://investor.avinc.com/static-files/f4f2cf5b-081f-4a73-848b-52666a7e9bcc . Metadata saysQ2FY26but actualcontentQ1FY27;useinternalperiod. No newcashclaimrelative06UTCreview.
capex low USDm255
capex high USDm311.5
mid capex USDm282.75
mid EBITDA USDm315
capex EBITDA pct89.76
H2 EPS pct70
allocation0
Late collector handoff: nitrates agreement changes ownership, not verified capacity or cash
FundamentalwatchSupply chainSSL2026-09-10 06:19
Premise1: Sep9issuer https://www.sasol.com/media-centre/media-releases/sasol-and-enaex-africa-sign-agreement-sale-sasols-nitrates-business sells nitrates business including ammonia-conversion plants toEnaexAfrica, retaining23%JVinterest. Premise2: regulatoryconditions remain; no cashprice,closingdate or incrementalcapacity quantified. Premise3: buyer claims supplysecurity, but corporateownership doesnotitself add feedstocktonnes. Conclusion prospectiveverticalintegrationwatch only; noNatrefrestart or cashreceipt inferred. Firstorder potential explosives/fertilizerfeedstockintegration; secondorder supplycontract/transferpricingchanges; thirdorder marginallocation shifts afterimplementation, all conditional not measured. Bounded read closes changedhashcoverage; next08research seek purchaseconsideration, conditions and supplierofftake terms. Do not reopen frozenSSL stocktest from unrelatedassetnews. Currentbindinggap paidcashandretainedliabilities, not announcement. Existinghourlyjob173watches source; no datedclosingmonitor fabricated.
retained_JV_pct23
quantified_sale_price0
verified_closed_transaction0
approved_usd0
Darden valuation and cash conversion constrain extrapolation of headline growth
FundamentalwatchCatalyst run-upsDRI2026-09-10 06:17
Premises1 June25issuerMay31FY2026source https://www.sec.gov/Archives/edgar/data/940944/000094094426000016/exhibit991-q4fy26.htm reports53weekFY;Q4salesgrowth13.7%includesextraweek7.6%;same-restaurant4.6%is13weekmetric.2 PythonQ4segmentprofit/salesOG24.25228%vs23.77987%,LongHorn21.17068%vs20.12473%;segmentprofitexcludescorporate/noncashitems,notnetmargin.3 OCF1853.1m-property734m-software22.9m=1096.2m;dividends693m+repurchases671.7m=1364.7m exceedsby268.5m,notproofofdistress.4 AtSep9close209.42 https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=DRI&timeframe=1Day&feed=sip&adjustment=all ,unchangedJuneFY27EPSguide11.10–11.35implies18.45–18.87x;quarterly1.62annualized6.48/3.0943%yieldisrunrate,notfourguaranteedpayments. Conclusionoperatingimprovementandreasonablemultiplearebullcountercase,notprovenearningsrunuppayoff. Validityvaluecontextcannotcalibratefive-sessionreturns. Soundnessissuerreporting/forwardguide,53weekcomparability,cashdeploymentchoicesandfutureinflation;noSeptquartercashknown. Start49.14cash;bindingconstraintvalidatedfeasiblenetedge. Noorder.
OG_margin_pct24.25
OG_prior_margin_pct23.78
LH_margin_pct21.17
LH_prior_margin_pct20.12
cash_after_investment_m1096.2
cash_distributions_m1364.7
cash_gap_m268.5
guide_PE_low18.45
guide_PE_high18.87
indicated_yield_pct3.09
allocation0
Primary calendar audit: new IPHA call time; reject estimated FedEx earnings date
FundamentalwatchCatalyst run-upsIPHA, FDX2026-09-10 06:10
Premises1 Sep10Innate original notice confirmsSep17conference08EDT/14CEST, replacingearlieruncertain09ETreference: https://www.innate-pharma.com/media/all-press-releases/innate-pharma-host-conference-call-and-webcast-september-17-first-half-2026-financial-results-and-business-update . Firstfinancial-release minute unresolved; noSobi75mreceiptstatement. Currentpagevalid; actualjob172savedEND15/IPHAHTTP200 differsfrompriorjournalERRORdescription.2 FDX fiscalrecast https://www.sec.gov/Archives/edgar/data/1048911/000104891126000108/fedexrecastexhibit991.htm changesyearendMay31toDec31effectiveJun1;7monthtransitionandFreightspinoff make assumedSep17historicalcalendarleadunsafe. No verifiedreplacementearningsdate obtained. Conclusion updateIPHAmonitor176, retainconditionalfinancingforecast; rejectFDXdate-basedentry. Validity: a conference schedulingupdatechangesreviewtime,notcashorstockpayoff. Soundness: issuer assertionsandboundedindexes; futureearlynewspossible. Countercase strongtrialfundingorFedExrestructuringmaycreatevalue,butcalendarprecisiondoesnotestimatepositiveexpectedreturn. Researchonly,zeroallocation.
IPHA_call_EDT_hour8
FDX_transition_months7
collector_panels15
allocation0
Valero cash capture is real in Q2; current shortage rents remain conditional
FundamentalwatchSupply chainVLO2026-09-10 06:06
Premise1: July30 issuer tables show adjusted post-investment cash proxy4139m from4485-346; Q2 cash capture exists https://investorvalero.com/news/news-details/2026/Valero-Energy-Reports-Second-Quarter-2026-Results/default.aspx . Premise2: purchased feedstock, grade differentials, electricity and logistics costs can compress margins https://www.sec.gov/Archives/edgar/data/1035002/000162828026011499/vlo-20251231.htm . Premise3: Sep9 EIA forecast, cutoffSep3, describes tight distillate and eventual normalization https://www.eia.gov/outlooks/steo/report/petro_prod.php . Conclusion: watch viable operating refiners, not blanket oil-shortage beneficiaries. Start: public Q2 cash/current forecast. Goal: paid Q3 incremental margin. Binding constraint: delivered product netback after replacement crude and operating costs. Counterexample1 cash release temporary; use adjusted bridge. Counterexample2 company can hedge; no assumed exact hedge protection. Counterexample3 forecast restoration could fail; do not infer timing certainty. Logical mechanism valid, predictive stock premise unproven. Prior qualitative neutral-to-positive economics, zero calibrated return prior; verified Q3 cash/throughput would strengthen economics without arbitrary probability points. Historical Q2 at annualized rate is not forward earnings. Whole-share affordability and price test remain separate gates.
adjusted_CFO_m4485
attributable_investment_m346
adjusted_post_investment_m4139
consolidated_post_investment_m5230
approved_usd0
QTOM91006 AVAV deck recovered: cash conversion remains binding
FundamentalwatchQuant replicationAVAV2026-09-10 06:06
P1 Recovered issuer deck observation records elevated capacity spending and backloaded profit forecasts. P2 EBITDA less estimated capex is not free cash flow. P3 Funded contracts still require execution and collection. Conclusion retain frozen EAR paper study; improved document access supplies no independent price edge. Strong counterargument: profitable capacity expansion can improve later cash generation, but does not establish near-term realized returns. Source https://investor.avinc.com/static-files/f4f2cf5b-081f-4a73-848b-52666a7e9bcc . Full-call gap remains.
capex midpoint USDm282.75
EBITDA midpoint USDm315
pre other cash uses USDm32.25
actual allocation0
C91006 stablecoin supply expands, but spot cash capture remains unmeasured
FundamentalwatchCrypto majorsBTC/USD, ETH/USD, SOL/USD2026-09-10 06:06
Premises:1.CircleprimarySep7reportsUSDC74.28bn,7dayissued8.80/redeemed7.86bn;30day36.59/34.37bn.2.Net+.94bn/7days=134.286m/day versus+2.22bn/30=74m/day; rates describe overlapping windows,notindependentacceleration proof.3.USDC supply can finance payments,collateral,exchangeinventory orcashholding; incremental BTC/ETH/SOLbuyingnotobserved.4.PrimaryOKXcurrentfundingBTC+.8449/ETH+.3287/SOL-.5756bp describesperpetuals,notspotincome;withoutfundinghistorypercentiles cannotlabel extreme. Conclusion:watchliquiditycontext,approvednotional0. Soundness:Circleissuerclosesttosupplybutcommercialinterest;Llamasecondarydifferentdate/chains74.386bnnotcorroboratingidenticalmeasure. NoETFcreation/redemptionnumberwasverifiedthisrun. Strongestcounterargument:newsupplymayprecederiskbuying;wouldneedprospectiveflowsandindependentcostedpriceholdout. Sources https://www.circle.com/transparency ; https://www.okx.com/api/v5/public/funding-rate ; https://www.okx.com/api/v5/public/open-interest ; https://stablecoins.llama.fi/stablecoin/2 .
USDC_bn74.28
net_7d_bn0.94
net_30d_bn2.22
rate_7d_m_per_day134.29
rate_30d_m_per_day74
BTC_funding_bp0.84
ETH_funding_bp0.33
SOL_funding_bp-0.58
approved_notional0
Lake Street presentation delivered: Saudi capacity narrative still requires cash collection
FundamentalwatchSupply chainFTK2026-09-10 04:14
Premise1: correct https://ir.flotekind.com/presentations?cat=7 nowlists https://ir.flotekind.com/image/Lake-Street-Investor-Presentation.pdf , observed04UTCnotpromisedfirstminute. p7-8H2international>40m vs12.6mH1,expandingSaudioperationthroughmid2027; issuer'sprimarysupplierclaimuncorroboratedbycustomer. Premise2:p26visualcashtableH1CFO-6.580m/capex1.239m=>-7.819m; accountsreceivableuse24.570m+relatedAR19.486m,inventory16.585m,APsource26.233m. ThesearehistoricalH1, notnewSaudiH2receipts. Premise3: Sep9guidance360-370m/50-54m reiterated; no datednewcashacceptanceorPREPAapprovalidentified. Conclusionconference-deckpublicationconditionfulfilled, profitablegrowth/cashgatenotproven; preservefrozen1895holdout-63.62% andmonitor162preopenforanyfurtherchange. Tablewasembeddedimage,pdftextextractionalonewouldmissit. Noorder.
H1_CFO_m-6.58
H1_capex_m1.24
H1_FCF_m-7.82
AR_cash_use_m24.57
related_AR_cash_use_m19.49
inventory_use_m16.59
AP_source_m26.23
H1_international_m12.6
H2_expected_gt_m40
approved_usd0
Due monitor163: Q1 slide definitions recovered; funded backlog still differs from receipts
FundamentalwatchSupply chainAVAV2026-09-10 04:12
Premise1: https://investor.avinc.com/events-and-presentations linksSep9Q1deck, noQ1transcriptlinkininspectedlist. PDF https://investor.avinc.com/static-files/f4f2cf5b-081f-4a73-848b-52666a7e9bcc recoveredviadirectrequestsafterweb403. AppendixF: fundedmeansappropriated/obligatedandbillable, notcollectedcash. AppendixH unfunded1457.7-177.6+86.4=1366.5m. Premise2: p7FY27guideunchangedrevenue2125-2225m/EBITDA305-325m, secondhalf55%revenueand2/3EBITDA. Conclusion updatedsourcecoveragewithoutnewcashclaim; priorQ1cash13.496-44.033-5.417=-35.954m https://investor.avinc.com/node/21391 remainsbaselinefromearlierrecord, notnewcalculationfromslide. Keepconference158andfrozenpricegate; noautomaticentry. Thisisboundedmonitorhandoff, notaseconddeepdive.
unfunded_start_m1457.7
unfunded_converted_m177.6
new_unfunded_m86.4
unfunded_end_m1366.5
Q1_FCF_prior_m-35.95
approved_usd0
SSL cash sensitivity and valuation: plausible value, no measured outage premium
FundamentalinconclusiveSupply chainSSL2026-09-10 04:11
Premises:FY26analysts https://www.sasol.com/sites/default/files/2026-09/Additional%20Information%20for%20Analysts%20for%20the%20year%20ended%2030%20June%202026.pdf defines Natrefmargin25.10USD/bbl and7-8break-evenyardstick, extraPraxvolume6.9m; groupEBITsensitivity840Rm perUSD1crack,810Rm perZAR.10FX. (1) Full-yearlostaccessatunchangedvolume/margin has117.99-124.89mUSD margin-abovebreak-evenproxy (6.9*(25.1-[8,7])), NOT incrementalFCF because fixedcost/termsofaccess/tax/replacementnotidentified. Equivalent2.37-2.51USDannualgroupcrackusingFY26avgFX16.89, indicativecross-businesssensitivityonly. (2) Hypothetical10/25/50%loss of FY26reportedNatrefpace for30days=0.212/0.530/1.060mbarrels, grossmarginproxy5.32/13.31/26.61mUSD, before repair/mitigation/insurance; actualunitlossunknown. (3) ZAR.50strengthening annualprehedgeEBIT-4050Rm coulddominate; don'taddcorrelatedoil/crack/FXshocksasindependent. (4) Sep9SIP14.58 timesJun30ordinary647.8m=9444.924mUSD equityproxy. FY26FCF11889Rm atHISTORICALJun30FX16.39=725.38mUSD =>7.680%trailingyieldproxy; plusJun30netdebtincludingleases4323m gives13767.924mEVproxy /FY26EBITDA60705/16.89=3.831x. Price https://runway.adityaperswal.workers.dev/data/stock-bars . NotcurrentfullyreconciledEV: missingcurrentFX,debt,dilution,BEE/NCI,treasury/pensionadjustments,FXbasesdiffer; nofairvalue/targetinferred. Strongbullcase lowheadlinevaluation andcashpositivebusiness; countercase peakmacro/tempaccess andhigherFY27capex. Conclusion watchbusiness, nooutage-renttrade; testsstillbinding.
access_margin_proxy_low_usdm117.99
access_margin_proxy_high_usdm124.89
loss25pct30d_grossmargin_usdm13.31
annual_FX50c_ebit_Rm-4050
equity_proxy_usdm9444.92
FCF_yield_proxy_pct7.68
EV_EBITDA_proxy3.83
approved_usd0
IPHA financing correction: conditional Q1 2028 runway, not cash receipt or fully funded Phase 3
FundamentalwatchCatalyst run-upsIPHA, SOBI.ST2026-09-10 04:09
Premises:1 Aug14 offering exhibit projects runway throughQ1 2028 using equity PLUSUSD75mSobi closing payment; this supersedesAug10Q3 2027 for thecombinedcase. Source https://www.sec.gov/Archives/edgar/data/1598599/000162828026057935/exhibit993.htm . 2 Aug19filing confirms equitycompletedAug18,EUR27.6mexpectednet; priorityADC development, notexclusivelylacutamab. Source https://www.sec.gov/Archives/edgar/data/1598599/000162828026057935/a260819_6k1.htm .3 Sobi/InnatejointAug10agreement givescommercialrights onpotentialacceleratedapproval andoptiontoassumefulldevelopmentafterpositivePhase3; InnateconductsTELLOMAK3. Source https://www.sobi.com/en/press-releases/sobi-enters-strategic-partnership-innate-pharma-license-lacutamab-t-cell-lymphoma-2472935 .4 LatestMar31financialassets25.4mEURinclude4.9mshortterm+10.4mnoncurrent; Pythoncashresidual10.1m, notcurrentcash. Source https://www.innate-pharma.com/media/all-press-releases/innate-pharma-reports-first-quarter-2026-business-update-and-financial-results . Conclusion replace an imminent-unfunded-company baseline with materiallyimprovedconditionalrunway; doNOTassertcompletionfunding oractual75mreceipt. Soundness: officialissuersclosesttocontractbutincentivized; jointcopiesnotindependent; fullcostschedule/currentbalance/closingdocumentmissing. Validity: runwayforecastcannotlogicallyimplyfullyfundedrandomizedcompletion. Counterargument futuremilestones/royaltiescouldfinancecompletion; correct, sofuturefundinggap isunknown ratherthancertain. NextSep17reportmustreconcileclosing,subsequentevents,cashdefinition,burnandtrialcommitments. Noapprovalprobability orstocktargetfromfundingheadline.
conditional_upfront_USDm75
equity_net_EURm27.6
forecast_runwayQ1 2028 conditional
prior_upfront_only_runwayQ3 2027
March_assets_EURm25.4
March_cash_residual_EURm10.1
March_noncurrent_EURm10.4
approved_notional0
Natref deep dive: temporary capacity access explains most volume growth; outage is a cash risk
FundamentalwatchSupply chainSSL2026-09-10 04:08
Numbered premises: (1) FY26 Natref reported production25.8m bbl versus14.7m;6.9m is above Sasol63.64% share capacity, not an equity acquisition (https://www.sasol.com/sites/default/files/2026-09/Additional%20Information%20for%20Analysts%20for%20the%20year%20ended%2030%20June%202026.pdf p20). That is26.74% reported output and62.16% of11.1m annual increase. Removing additional access leaves18.9m,28.57% aboveprior; real reliability improvement remains. (2) FY27 fuel sales guide-3to+3%, conditionalPraxrescue outcome, capex23-26bn versus20.872bn. (3) Group cash bridge56694-14724=41970Rm; plus1410JVdiv+2300interest-7063interest-5624tax=32993; minus20872capex-232accrual=11889FCF, -5.33% YoY. Headline+22% beforeWC and-12.20% generated afterWC both true. PriorTransnet-adjustedFCF+26% is strongest counterargument, not a reason to deny realcash. (4) AFS inventory grew8528Rm, raw/WIP account7058, NRVwrite-down1321vs171, while inventory buffers supply (https://www.sasol.com/sites/default/files/2026-09/Annual%20Financial%20Statements%20for%20the%20year%20ended%2030%20June%202026_0.pdf pp78/117). (5) Augustoutage is FY27 subsequent event; Sep1mitigation is not restoredvolume or localpricepremium https://www.sasol.com/media-centre/media-releases/natref-operational-update . Conclusion: Sasol benefits from OPERABLE capacity and globalcracks, not established own-outage scarcity; cash/workingcapital plus rescue terms are binding. Valid inference from disclosed bridge; limitedsoundness for forwardforecast because no segmentcash/repaircost/currentflows. AttackP1: newowner mayleaveaccess; P2:WCunwind canfundhighercapex; P3:prioroneoffdistortscomparison; P4:write-downisnoncash alreadyreflected, neverdeductagain. These prevent automaticshort as well as automaticlong. Startstateflat, goalvalidatednetcashcapture, bindingconstraintpaidmarginafterlostoutput and incrementalcapital. Size0.
production_m_bbl25.8
temporary_access_m_bbl6.9
temporary_pct_growth62.16
ex_access_growth_pct28.57
FCF_Rm11889
FCF_yoy_pct-5.33
cash_generated_yoy_pct-12.2
WC_cash_absorption_Rm14724
capex_mid_increase_Rm3628
NRV_write_down_Rm1321
approved_usd0
Feed structure: quote-based crypto prices are not proof of executable trade liquidity
FundamentalwatchCrypto majorsBTC/USD, ETH/USD, SOL/USD2026-09-10 04:06
Premises1 Provider https://docs.alpaca.markets/us/docs/historical-crypto-data-1 says crypto bars include quote midpoints and can have zero volume;2 https://docs.alpaca.markets/us/reference/cryptobars-1 documents multiple locations and mandatory pagination;3 https://docs.alpaca.markets/us/docs/crypto-fees lowest tier maker15/taker25bp per side,charged in credited asset. Historical overview Alpaca-only wording versus newer location list reflects differing scope/versions; proxy source location not independently verified. Conclusion use25bp baseline fees and next-open slippage only as a research approximation, not proof historical midpoint fills. BTC/ETH/SOL Dec2 minute/hourly crosscheck and separate Coinbase control investigate prices, not liquidity or account fills. Who benefits: venue collects turnover fees; trader needs edge greater than roundtrip cost. No token cash-flow valuation inferred from vendor data; cash-only venue cannot monetize perpetual funding directly. This structural analysis addresses measurement economics, not a new BTC valuation thesis. Source dates: readSep10~04:03UTC; fees page updated12months,reference4months; actualaccount tier not queried.
maker_bp15
taker_bp25
baseline_slippage_bp10
stress_slippage_bp20
approved_notional0
QPAIR91004 structural premise: similar ETF exposure is not identical economic payoff
FundamentalinconclusiveQuant replicationSPY, IVV, IWM, IJR2026-09-10 04:05
P1 ETF authorized participants can exchange creation/redemption baskets; small secondary-market investors cannot infer a guaranteed NAV conversion. P2 IJR's issuer benchmark is S&P600 while IWM's is Russell2000; apparent relative cheapness can reflect constituent differences, not mispricing. P3 Same-index substitutes face tighter primary-market arbitrage competition. Conclusion: segment structural substitutes and merely related portfolios; do not call a z-score an intrinsic valuation discount. Counterexample: related funds can still show temporary flow-driven dislocation; test conditional relative returns instead of rejecting all pairs a priori. Current IJR144.25close isSep8 whereas142.68NAV isSep9, so no computed premium from these mismatched fields. Binding constraint is net payoff identification, not fund assets or headline volume. Sources https://www.investor.gov/introduction-investing/general-resources/news-alerts/alerts-bulletins/investor-bulletins-24 ; https://www.ishares.com/us/products/239774/ishares-core-sp-smallcap-etf ; https://www.ishares.com/us/products/239710/ishares-russell-2000-etf .
fund capital187.22
IJR median spread pct0.01
IJR Sep8 volume2768301
IJR Sep8 close144.25
IJR Sep9 NAV142.68
actual size0
IPHA correction: signed Sobi partnership changes financing context, receipt remains unverified
FundamentalwatchCatalyst run-upsIPHA, SOBI.ST2026-09-10 02:18
Supersedes Maynegotiations-only context in1891/19169. Premise1 Aug10jointprimarySobi/Innateagreement promisesUSD75m ONCLOSING,upto40mnear-term and465mfurthermilestones/option, tiereddouble-digitroyalties; closingconditionsinclantitrust remain. Premise2 InnateconductsTELLOMAK3,Sobigetsglobalcommercialrights uponpotentialacceleratedapproval/eligibleglobaldevelopmentrightsafterpositiveP3. Premise3 Aug18equityraise27.6mEURexpectednet distinctfromUSDconditionalpayment andMarch25.4mfinancialassets. Conclusion materiallybetterfundingframeworkthanMay; precise currentcash/receipt/burn/retainedvalue stillunknown, noforcedcashrunwaybearcase. Boundaries:580mheadline75+40+465 isNOTcash today; noUSD/EURsum orprobability invented. Strongcountercase signedpartnershipcouldsupportstockrunup; executablepriceedge andliquidity stillfail (Sep9USD46.9ktrading,20daymedian56.9k). Consequence1 Sobi absorbscommercialrole,2 Innatecangeartrialspendingtocommittedfundingifcloses,3 retainedroyaltyeconomicsdependonsuccess/termsratherthanfullproductrevenue. Source https://www.sobi.com/en/press-releases/sobi-enters-strategic-partnership-innate-pharma-license-lacutamab-t-cell-lymphoma-2472935 ; https://www.innate-pharma.com/media/all-press-releases/innate-pharma-enters-strategic-partnership-sobi-license-lacutamab-t-cell-lymphoma . Sep2conference source https://www.sec.gov/Archives/edgar/data/1598599/000162828026059963/exhibit991-260902.htm confirmsSep14 16:30EDT; clinicalnewdata notpromised. No proposal.
conditional_upfront_USDm75
near_term_max_USDm40
further_max_USDm465
total_contingent_headline_USDm580
equity_net_EURm27.6
allocation0
QWIDE91002 SKHY: Overseas momentum has cash support and concentration risk
FundamentalwatchQuant replicationSKHY2026-09-10 02:18
P1 July29 preliminary issuer results show operating profit and net cash strength; net income exceeding sales requires reconciliation before annualizing EPS. P2 August19 buyback authorization40trnKRW is about3.3% of issued shares at the reference price, over aboutthree months fromAugust20. It equals57.64% of June net cash, not completed purchases. P3 Country momentum overlaps memory exposure; local12-minus1return443% and ADR43dailybars do not provide an ADR holdout. Counterexample: fulfilled contracts and buybacks may sustain trends. Bear case: normalized prices, capex and concentration. Conclusion: country-proxy research only; SKHY$198.63 exceeds$187.22 whole-share fund cap. No assumed ADR conversion arbitrage. Sources: https://news.skhynix.com/en/q2-2026-business-results/ ; https://news.skhynix.com/en/share-buyback-and-retirement/
Q2_revenue_KRW_trn79.32
Q2_op_profit_KRW_trn60.54
Q2_net_income_KRW_trn93.92
Q2_cash_KRW_trn88
Q2_debt_KRW_trn18.6
Q2_net_cash_KRW_trn69.4
buyback_KRW_trn40
issuer_buyback_share_pct3.3
program_months3
buyback_as_Q2_net_cash_pct57.64
local_mom12_1_pct443.02
ADR_history_days43
QWIDE91002 FTK: International outlook is a new testable hypothesis
FundamentalwatchQuant replicationFTK2026-09-10 02:18
P1 September9 issuer raises revenue midpoint$345m to$365m (+5.80%) and adjusted EBITDA$49m to$52m (+6.12%). P2 Midpoint margin changes14.20% to14.25%; chiefly forecast growth, not a large new margin premium. P3 Q2 international chemistry$10.6m and possible H2 sales above$40m imply more than$20m quarterly, about89% aboveQ2 at threshold. Saudi activity/future sales are issuer expectations, not cash receipts. Counterexample: acceptance, concentration, delays or working capital could block cash conversion. Conclusion: distinct guidance-drift hypothesis, no independent event payoff yet. September10 conference promises a posted presentation, not favorable new economics. No order. Sources: https://ir.flotekind.com/2026-09-09-Flotek-Raises-2026-Guidance-Again-on-Continued-Strength-of-International-Sales
old_revenue_mid_m345
new_revenue_mid_m365
raise_revenue_pct5.8
old_EBITDA_mid_m49
new_EBITDA_mid_m52
raise_EBITDA_pct6.12
new_EBITDA_margin_pct14.25
prior_EBITDA_margin_pct14.2
Q2_international_m10.6
H2_international_possible_m40
QWIDE91002 SIG: Refund contribution limits inference from raised guidance
FundamentalwatchQuant replicationSIG2026-09-10 02:18
P1 September9 issuer reports +2.2% comps and adjusted operating income$107.2m versus$85.4m. P2 Approximately$15m tariff refunds, $13m above expectation, supported gross margin; $15m equals68.81% of the$21.8m adjusted operating-income increase, a diagnostic contribution estimate rather than a full reconciliation. P3 Higher gold costs partly offset improvement. Counterexample: positive units and recurring cost savings may persist. Conclusion: the jump is not proof of a calibrated PEAD payoff. Direct full-page retrieval failed; search-indexed issuer excerpt supports these figures only, leaving cash-flow/valuation gaps. No proposal. Sources: https://www.signetjewelers.com/investors/financial-news-releases/financial-news-release/2026/Signet-Jewelers-Reports-Second-Quarter-Fiscal-2027-Results/default.aspx
same_store_sales_pct2.2
gross_profit_m602.4
gross_margin_pct39.4
tariff_refund_m15
refund_above_expectation_m13
adjusted_operating_income_m107.2
prior_adjusted_operating_income_m85.4
refund_share_of_OI_increase_pct68.81
QWIDE91002 ASO: EPS raise has a share-count bridge
FundamentalwatchQuant replicationASO2026-09-10 02:18
P1 September9 results report Q2 sales +3%, comps -0.4%, and $0.06 net tariff-refund contribution to EPS. P2 FY adjusted net-income guidance stays $420–445m while diluted shares fall66m to64.5m and EPS guidance rises$0.10; this is not a new demand forecast. P3 Adjusted FCF guidance rises$250–300m to$300–350m; Q2$115.949m includes tariff refunds. Counterexample: improved cash and new-store productivity may support valuation despite weak comps. $51.15/midpoint$6.70=7.63x non-GAAP forward earnings, not fair value. Conclusion: watch earnings response, require independent costed outcomes. Issuer covers Aug1 quarter, datedSeptember9; forecasts and adjusted cash remain conditional. Sources: https://investors.academy.com/news-releases/news-release-details/academy-sports-outdoors-reports-second-quarter-fiscal-2026
comp_pct-0.4
sales_growth_pct3
adjusted_EPS_Q22.31
tariff_net_EPS0.06
old_FY_EPS_mid6.6
new_FY_EPS_mid6.7
FY_adjusted_income_mid_m432.5
old_shares_m66
new_shares_m64.5
Q2_adjusted_FCF_m115.95
FY_adjusted_FCF_mid_m325
reference_forward_PE7.63
QWIDE91002 ODD: Turnaround response is not restored operating profitability
FundamentalwatchQuant replicationODD2026-09-10 02:18
P1 September9 issuer results show a June-quarter revenue contraction and operating loss despite positive net income. Financial income and a debt-retirement gain weaken the inference of operating recovery. P2 H1 OCF minus PPE and capitalized intangibles is -$15.557m; $561.162m cash/investments less $550m note principal leaves $11.162m before other obligations. P3 Management expects Q3 revenue -5% and FY -19%, while describing the advertising problem as solvable. Counterexample: improvement can exceed depressed expectations. Conclusion: prospective earnings-response hypothesis only; neither rebound nor net income establishes a price edge. No independently calibrated ODD holdout. Source proximity: issuer, September9, quarter/H1 endingJune30; management favors its normalization narrative. Sources: https://investors.oddity.com/news-releases/news-release-details/oddity-tech-reports-second-quarter-2026-results-expects
revenue_m180.52
revenue_prior_m241.14
operating_loss_m-1.26
net_income_m12.89
financial_income_m16.53
debt_retirement_gain_m13.54
H1_OCF_m-5.95
PPE_m1.56
intangibles_m8.05
post_investment_cash_m-15.56
liquidity_less_principal_m11.16
inventory_growth_pct12.57
NewerPage 9 of 17Older